Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026)
Zai Lab (ZLAB) posted Total Current Liabilities of $393.0 million for Q1 2026, down 5.57% sequentially from $416.2 million in Q4 2025, and up 22.88% YoY from $319.8 million in Q1 2025.
Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026) Analysis & Trends
Zai Lab has reported Total Current Liabilities for 11 years, with the latest figure at $393.0 million in Q1 2026.
- Quarterly Total Current Liabilities rose 22.88% year-over-year to $393.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $393.0 million (up 22.88% YoY) and the FY2025 annual result came in at $416.2 million, up 39.01% from the prior year.
- Total Current Liabilities eased to $393.0 million in Q1 2026 per ZLAB's latest filing, from $416.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $416.2 million in Q4 2025 and troughed at $124.6 million in Q1 2023.
- A 5-year average of $238.5 million and a median of $203.1 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities declined 27.51% in 2022, then jumped 129.24% in 2024.
- Over 5 years, Total Current Liabilities stood at $139.8 million in 2022, then surged by 45.21% to $203.1 million in 2023, then jumped by 47.43% to $299.4 million in 2024, then soared by 39.01% to $416.2 million in 2025, then decreased by 5.57% to $393.0 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $393.0 million, $416.2 million, and $359.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 428.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 428.58 Mn |
| Mar 31, 2026 | 392.98 Mn |
| Dec 31, 2025 | 416.17 Mn |
| Sep 30, 2025 | 359.77 Mn |
| Jun 30, 2025 | 331.50 Mn |
| Mar 31, 2025 | 319.81 Mn |
| Dec 31, 2024 | 299.39 Mn |
| Sep 30, 2024 | 286.32 Mn |
| Jun 30, 2024 | 251.72 Mn |
| Mar 31, 2024 | 192.11 Mn |
| Dec 31, 2023 | 203.07 Mn |
| Sep 30, 2023 | 124.90 Mn |
| Jun 30, 2023 | 133.35 Mn |
| Mar 31, 2023 | 124.56 Mn |
| Dec 31, 2022 | 139.84 Mn |
| Sep 30, 2022 | 155.55 Mn |
| Jun 30, 2022 | 168.88 Mn |
| Mar 31, 2022 | 154.91 Mn |
| Dec 31, 2021 | 192.90 Mn |
| Sep 30, 2021 | 112.01 Mn |